Kamisaki Y, Wada K, Bian K, Balabanli B, Davis K, Martin E, Behbod F, Lee Y C, Murad F
Department of Integrative Biology and Pharmacology, University of Texas-Houston Medical School, 6431 Fannin, Houston, TX 77030, USA.
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11584-9. doi: 10.1073/pnas.95.20.11584.
Homogenates from rat spleen and lung could modify nitrotyrosine-containing BSA. With incubation, nitrotyrosine-containing BSA lost its epitope to a monoclonal antibody that selectively recognized nitrotyrosine-containing proteins. In the presence of protease inhibitors, the loss of the nitrotyrosine epitope occurred without protein degradation and hydrolysis. This activity was found in supernatant but not particulate fractions of spleen homogenates. The factor was heat labile, was sensitive to trypsin treatment, and was retained after passage through a membrane with a 10-kDa retention. The activity was time- and protein-concentration dependent. The activity increased about 2-fold in spleen extracts with endotoxin (bacterial lipopolysaccharide) treatment of animals, suggesting that the activity is inducible or regulatable. Other nitrotyrosine-containing proteins also served as substrates, while free nitrotyrosine and some endogenous nitrotyrosine-containing proteins in tissue extracts were poor substrates. Although the product and possible cofactors for this reaction have not yet been identified, this activity may be a "nitrotyrosine denitrase" that reverses protein nitration and, thus, decreases peroxynitrite toxicity. This activity was not observed in homogenates from rat liver or kidney, suggesting that there may also be some tissue specificity for the apparent denitrase activity.
大鼠脾脏和肺的匀浆能够修饰含硝基酪氨酸的牛血清白蛋白(BSA)。随着孵育进行,含硝基酪氨酸的BSA失去了其对一种选择性识别含硝基酪氨酸蛋白质的单克隆抗体的表位。在蛋白酶抑制剂存在的情况下,硝基酪氨酸表位的丧失在没有蛋白质降解和水解的情况下发生。这种活性存在于脾脏匀浆的上清液中,而不存在于颗粒部分。该因子对热不稳定,对胰蛋白酶处理敏感,并且在通过截留分子量为10 kDa的膜后仍保留。该活性具有时间和蛋白质浓度依赖性。用内毒素(细菌脂多糖)处理动物后,脾脏提取物中的活性增加约2倍,这表明该活性是可诱导的或可调节的。其他含硝基酪氨酸的蛋白质也可作为底物,而游离硝基酪氨酸和组织提取物中的一些内源性含硝基酪氨酸的蛋白质则是较差的底物。尽管该反应的产物和可能的辅因子尚未确定,但这种活性可能是一种“硝基酪氨酸脱硝酸酶”,它可逆转蛋白质硝化作用,从而降低过氧亚硝酸盐的毒性。在大鼠肝脏或肾脏的匀浆中未观察到这种活性,这表明这种明显的脱硝酸酶活性可能也存在一些组织特异性。